[ad_1] KMX Investors with Losses Encouraged to Contact the Firm SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — On November 6, 2025, investors in CarMax, Inc. (NYSE: KMX) saw shares plummet $9.93 (-24%) after the company […]
Tag: Hagens Berman Sobol Shapiro LLP
MoonLake Immunotherapeutics’ (MLTX) Stock Crashes 90%, Triggers Lawsuit After Reported Phase 3 Trial Data for Sole Drug Candidate — Hagens Berman
[ad_1] SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company, has been hit with a securities fraud class action lawsuit after its share price plummeted nearly 90% in a […]
Hagens Berman Urges aTyr Pharma Investors to Act by Dec. 8 Deadline in Suit Over Trial Failure
[ad_1] Legal Focus on Drug Efficacy: Partner Reed Kathrein Scrutinizing Alleged Misrepresentations of Efzofitimod’s Steroid-Tapering Capability SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — Global plaintiffs’ rights law firm Hagens Berman reminds investors of the December 8, […]
Inspire Medical (INSP) Faces Securities Class Action Over Claims It Misled Investors on Next-Generation Device Launch — Hagens Berman
[ad_1] SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — Medical device manufacturer Inspire Medical Systems, Inc. (NYSE: INSP) is the subject of a securities class action lawsuit following a sharp decline in its stock price, with […]
James Hardie Industries (JHX) Lawsuit Alleging Securities Fraud Over Inventory Misstatements Pending, CFO Replaced — Hagens Berman
[ad_1] JHX Investors with Losses Encouraged to Contact Hagens Berman SAN FRANCISCO, Nov. 28, 2025 /PRNewswire/ — On November 17, 2025, James Hardie Industries plc (NYSE: JHX) announced the departure of its CFO (Rachel Wilson) […]
